AccuStem Sciences

AccuStem Sciences is a clinical-stage diagnostic company dedicated to improving the quality of life and outcomes for more than 18 million people diagnosed with cancer worldwide each year. AccuStem Sciences' mission is to provide innovative diagnostic tools that optimize outcomes and quality of life for all patients throughout the entire oncology care continuum, from cancer screening to treatment and monitoring. AccuStem aims to drive innovation and cost savings in healthcare by offering a novel set of molecular tools that enable multidisciplinary care teams to make more informed decisions.